Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD-3839 hemifumarate is a potent and selective BACE1 inhibitor and clinical candidate for the treatment of Alzheimer's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | AZD-3839 hemifumarate is a potent and selective BACE1 inhibitor and clinical candidate for the treatment of Alzheimer's disease. |
Molecular Weight | 978.92 |
Formula | C52H36F6N10O4 |
CAS No. | 1421852-78-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD-3839 hemifumarate 1421852-78-9 AZD-3839 BW 2258U89 BW-10 AZD-3839 Hemifumarate BW10 AZD 3839 AZD 3839 Hemifumarate AZD3839 AZD3839 Hemifumarate inhibitor inhibit